-
The enzymes in the Invitrogen deal will be used for PCR.
FORBES: Invitrogen Deal Proves Diversa's Worth
-
The first chemical alone could bring in millions of dollars, making it one of Invitrogen's top sellers, according to Lewis Shuster , Invitrogen's chief operating officer.
FORBES: Invitrogen Deal Proves Diversa's Worth
-
Before Invitrogen announced it had licensed these chemicals, Diversa had only one product on the market, an enzyme that cleans the hot depths of oil wells.
FORBES: Invitrogen Deal Proves Diversa's Worth
-
This week it struck a deal to license three chemicals to Invitrogen ivgn (nasdaq: ivgn - news - people), which makes products that accelerate the work of scientists doing genetic research.
FORBES: Invitrogen Deal Proves Diversa's Worth
-
Life Technologies, formed by the merger last year of life science tools companies Applied Biosystems and Invitrogen, has an estimated 65% of the market for PCR machines used for research and has licensed its technology to 12 other companies making the machines.
FORBES: Technology